Afya Limited (AFYA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Afya Limited (AFYA) trades at $13.76 with AI Score 56/100 (Hold). Afya Limited is a leading medical education group in Brazil, offering a comprehensive suite of educational products and digital health services. Market cap: 2B, Sector: Consumer defensive.
Last analyzed: Feb 7, 2026Afya Limited (AFYA) Consumer Business Overview
Afya Limited (AFYA) is revolutionizing medical education in Brazil, boasting a robust network of campuses and cutting-edge digital health solutions, positioning it as a leader in lifelong learning for healthcare professionals with a compelling 20.1% profit margin and a 1.50% dividend yield.
Investment Thesis
Afya Limited presents a notable research candidate due to its dominant position in the rapidly growing Brazilian medical education market. With a P/E ratio of 10.02 and a healthy profit margin of 20.1%, Afya demonstrates strong financial performance. The company's expansion into digital health services further enhances its growth potential by providing recurring revenue streams and increasing customer engagement. A key value driver is the increasing demand for medical professionals in Brazil, coupled with Afya's ability to secure and operate a significant number of medical school seats. The company's beta of 0.51 suggests lower volatility compared to the broader market, making it a noteworthy option for risk-averse investors. Upcoming catalysts include the potential for further acquisitions of medical schools and the continued expansion of its digital health platform, driving long-term value creation.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $1.40 billion, reflecting Afya's significant presence in the Brazilian medical education market.
- P/E ratio of 10.02, indicating a potentially undervalued stock compared to its earnings.
- Profit margin of 20.1%, showcasing strong profitability and efficient operations.
- Gross margin of 65.0%, demonstrating the high value of Afya's educational products and services.
- Dividend yield of 1.50%, providing investors with a steady income stream.
Competitors & Peers
Strengths
- Leading medical education group in Brazil.
- Comprehensive suite of educational products and services.
- Strong brand reputation and extensive network of campuses.
- Growing digital health services platform.
Weaknesses
- Reliance on the Brazilian economy and regulatory environment.
- Potential for increased competition in the medical education market.
- Exposure to currency fluctuations.
- Dependence on government accreditation for medical programs.
Catalysts
- Potential acquisitions of smaller medical schools to expand market share.
- Continued growth in digital health services subscriptions.
- Increasing demand for medical professionals in Brazil.
- Launch of new specialized educational programs.
- Strategic partnerships with healthcare institutions.
Risks
- Changes in government regulations affecting medical education accreditation.
- Economic downturn in Brazil impacting student enrollment and tuition payments.
- Increased competition from other educational institutions offering similar programs.
- Currency fluctuations affecting financial performance.
- Dependence on maintaining high-quality educational standards and student outcomes.
Growth Opportunities
- Expansion of Digital Health Services: Afya has a significant opportunity to expand its digital health services platform. The market for digital health solutions is rapidly growing, driven by the increasing adoption of technology in healthcare. By offering a comprehensive suite of digital tools and resources, Afya can attract a larger user base and generate recurring subscription revenue. This expansion can be achieved through strategic partnerships, new product development, and targeted marketing campaigns. The timeline for significant growth in this area is within the next 2-3 years.
- Acquisition of New Medical Schools: Afya can continue to grow by acquiring additional medical schools in Brazil. The Brazilian medical education market is fragmented, presenting opportunities for consolidation. By acquiring smaller institutions, Afya can expand its geographic reach, increase its student enrollment, and leverage its existing infrastructure and expertise. This strategy can be executed over the next 3-5 years, driving long-term growth and market share gains.
- Increased Enrollment in Existing Programs: Afya can focus on increasing enrollment in its existing medical education programs. With a network of 46 campuses and a strong reputation for quality education, Afya is well-positioned to attract more students. This can be achieved through targeted marketing, scholarships, and partnerships with healthcare institutions. Increased enrollment will directly translate into higher revenue and profitability. This is an ongoing opportunity with continuous improvement efforts.
- Development of New Educational Programs: Afya can develop new educational programs to meet the evolving needs of the healthcare industry. This includes offering specialized courses in areas such as telemedicine, data analytics, and artificial intelligence in healthcare. By expanding its program offerings, Afya can attract a wider range of students and generate new revenue streams. The timeline for developing and launching new programs is within the next 1-2 years.
- Strategic Partnerships with Healthcare Providers: Afya can form strategic partnerships with healthcare providers to offer practical training opportunities for its students. These partnerships can provide students with valuable hands-on experience and improve their job prospects after graduation. Additionally, partnerships can lead to research collaborations and the development of innovative healthcare solutions. These partnerships can be developed and expanded on an ongoing basis.
Opportunities
- Expansion into new geographic markets within Brazil.
- Development of new educational programs and services.
- Strategic partnerships with healthcare providers.
- Acquisition of additional medical schools.
Threats
- Changes in government regulations affecting medical education.
- Economic downturn in Brazil impacting student enrollment.
- Increased competition from other educational institutions.
- Technological disruptions in the education sector.
Competitive Advantages
- Strong brand reputation in the Brazilian medical education market.
- Extensive network of medical school campuses across Brazil.
- Comprehensive suite of educational products and services.
- Proprietary digital health platform with a large user base.
- High barriers to entry in the medical education market due to regulatory requirements.
About AFYA
Founded in 1999, Afya Limited has evolved into Brazil's premier medical education group. The company's core mission is to empower medical professionals throughout their careers by providing high-quality educational products and services. Starting with a vision to transform medical education, Afya has strategically expanded its offerings to include undergraduate medical schools, medical residency preparatory courses, graduate programs, and continuous education resources. Afya operates a network of 46 undergraduate and graduate medical school campuses, consisting of 30 operating units and five approved units as of December 31, 2021. These campuses house 2,731 medical school seats, including 2,481 operating seats and 278 approved seats, demonstrating Afya's significant capacity to educate future medical professionals. Beyond traditional education, Afya has embraced digital innovation through its digital health services, offering a subscription-based mobile app and website portal. This platform assists health professionals and students with clinical decision-making by providing tools such as medical calculators, charts, updated content, prescriptions, clinical scores, medical procedures, and laboratory exams. Afya's comprehensive approach, combining physical campuses with digital solutions, solidifies its position as a leader in the Brazilian medical education market.
What They Do
- Operate medical schools across Brazil.
- Provide medical residency preparatory courses.
- Offer graduate courses in healthcare-related fields.
- Provide digital health services through a subscription-based platform.
- Offer health sciences courses including medicine, dentistry, and nursing.
- Provide medical postgraduate specialization programs.
- Offer printed and digital content for medical education.
- Operate an online medical education platform.
Business Model
- Tuition fees from undergraduate and graduate medical programs.
- Subscription revenue from digital health services platform.
- Revenue from medical residency preparatory courses.
- Sales of printed and digital educational content.
Industry Context
Afya Limited operates within the growing education and training services industry in Brazil, specifically focusing on medical education. The demand for qualified medical professionals in Brazil is increasing, driving growth in the medical education sector. The industry is characterized by a mix of public and private institutions, with Afya being one of the leading private players. Competition includes other educational groups and universities, but Afya differentiates itself through its comprehensive offerings, including digital health services and a large network of campuses. The Brazilian education market is expected to continue growing, driven by demographic trends and government initiatives to improve healthcare access.
Key Customers
- Undergraduate medical students.
- Medical residents preparing for specialization.
- Practicing healthcare professionals seeking continuing education.
- Hospitals and healthcare institutions using digital health services.
- Third-party medical schools utilizing Afya's resources.
Financials
Chart & Info
Afya Limited (AFYA) stock price: $13.76 (+0.26, +1.93%)
Latest News
-
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price Performance
Yahoo! Finance: AFYA News · Mar 14, 2026
-
Afya Ltd (AFYA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Yahoo! Finance: AFYA News · Mar 14, 2026
-
Reported earlier, Afya Sees FY2026 Sales $731.710M-$759.496M vs $763.950M Est
benzinga · Mar 13, 2026
-
Afya's Q4 Adjusted Earnings, Revenue Increase; 2026 Revenue Guidance Issued
MT Newswires · Mar 13, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AFYA.
Price Targets
Consensus target: $16.75
MoonshotScore
What does this score mean?
The MoonshotScore rates AFYA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Education & Training ServicesCompetitors & Peers
Latest News
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price Performance
Afya Ltd (AFYA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Reported earlier, Afya Sees FY2026 Sales $731.710M-$759.496M vs $763.950M Est
Afya's Q4 Adjusted Earnings, Revenue Increase; 2026 Revenue Guidance Issued
Afya Limited Consumer Defensive Stock: Key Questions Answered
What does Afya Limited do?
Afya Limited operates as a medical education group in Brazil, providing a comprehensive range of educational products and services. These include undergraduate medical schools, medical residency preparatory courses, graduate programs, and digital health services. The company's mission is to empower medical professionals throughout their careers by offering high-quality education and innovative digital solutions. Afya's network of campuses and digital platform serve a diverse range of students and healthcare professionals, solidifying its position as a leader in the Brazilian medical education market.
Is AFYA stock worth researching?
AFYA stock presents a potentially attractive investment opportunity, supported by its strong market position and financial performance. With a P/E ratio of 10.02 and a profit margin of 20.1%, Afya demonstrates solid profitability. The company's growth potential is further enhanced by its expansion into digital health services and the increasing demand for medical professionals in Brazil. However, investors may want to evaluate the risks associated with the Brazilian economy and regulatory environment. A balanced analysis suggests that AFYA stock could be worth researching for investors seeking exposure to the growing medical education market in Brazil.
What are the main risks for AFYA?
Afya faces several key risks, including changes in government regulations affecting medical education accreditation, which could impact its ability to operate medical programs. An economic downturn in Brazil could reduce student enrollment and tuition payments, affecting revenue. Increased competition from other educational institutions could erode market share. Currency fluctuations pose a risk to financial performance, as Afya's revenue and expenses are denominated in Brazilian Real. Maintaining high-quality educational standards and student outcomes is crucial for maintaining its reputation and attracting students; failure to do so could negatively impact its brand and enrollment.
What are the key factors to evaluate for AFYA?
Afya Limited (AFYA) currently holds an AI score of 56/100, indicating moderate score. The stock trades at a P/E of 8.7x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $16.75 (+22% from $13.76). Key strength: Leading medical education group in Brazil. Primary risk to monitor: Changes in government regulations affecting medical education accreditation. This is not financial advice.
How frequently does AFYA data refresh on this page?
AFYA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AFYA's recent stock price performance?
Recent price movement in Afya Limited (AFYA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $16.75 implies 22% upside from here. Notable catalyst: Leading medical education group in Brazil. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AFYA overvalued or undervalued right now?
Determining whether Afya Limited (AFYA) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 8.7. Analysts target $16.75 (+22% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AFYA?
Before investing in Afya Limited (AFYA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on data available as of 2026-02-07. Future performance is subject to market conditions and company-specific factors.